Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00607230
Show Display Options
Rank Status Study
1 Completed Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: BCG;   Biological: Saline

Indicates status has not been verified in more than two years